Belgium· BE-AMP-SAM260662-00
Relestat 0.5 mg/ml
A epinastine product containing epinastine hydrochloride, registered in Belgium by Abbvie. The same ATC class is registered in 8 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Epinastine is registered in 8 of 19 countries.
Countries holding a registration under ATC S01GX10 (epinastine), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 5 of them publish a price we can compare per daily dose
Epinastine · ATC S01GX10
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Ireland
- Netherlands
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Epinastine Hydrochloride
- Manufacturer
- Abbvie
- Country
- Belgium (BE)
- ATC code
- S01GX10
- ATC class
- Epinastine
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb2124956
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Epinastine in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaPURIVISTAbbVie s.r.o., Praha
- FinlandRelestatAllergan Pharmaceuticals Ireland
- FrancePURIVIST 0,5 mg/ml, collyre en solutionABBVIE
- IrelandRelestat, 0.5 mg/ml, eye drops, solutionAbbVie Limited
- NetherlandsRelestat, oogdruppels, oplossing 0,5 mg/mlAbbVie B.V.
- PolandRelestatAbbVie Sp. z o.o.
- SwedenRelestat 0,5 mg/ml Ögondroppar, lösningAbbVie AB
- United StatesEPINASTINE HYDROCHLORIDESomerset Therapeutics, LLC
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Czechia · Purivist
- France · Purivist
- United Kingdom (Northern Ireland) · Relestat
- Greece · Optallerg, Relestat
- Hungary · Relestat
- Ireland · Relestat
- Italy · Relestat
- Luxembourg · Relestat
- Netherlands · Relestat
- Portugal · Relestat
- Sweden · Relestat
- Slovakia · Purivist
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/224400ef-9e3f-4c8d-9e41-70b20da3fc11 GET /v1/drugs/224400ef-9e3f-4c8d-9e41-70b20da3fc11?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Eye drops, solution",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Relestat 0.5 mg/ml",
"name_fr": "Relestat 0.5 mg/ml",
"name_nl": "Relestat 0.5 mg/ml",
"amp_code": "SAM260662-00",
"strengths": [
"0.5000",
"0.4360",
"0.1000",
"7.8000",
"0.5000",
"5.0000"
],
"pack_count": 1,
"substances": [
"Epinastine Hydrochloride",
"Epinastine",
"Benzalkonium Chloride",
"Disodium Edetate",
"Sodium Dihydrogen Phosphate Dihydrate",
"Sodium Chloride",
"Sodium Hydroxide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Epinastine",
"authorisation_numbers": [
"BE260662"
]
}See everything about epinastine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.